US Edition
Jenscare’s Lux-Valve Plus TTVR System Evaluated in TRINITY Study - Cardiac Interventions Today
Summary by Cardiac Interventions Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Jenscare’s Lux-Valve Plus TTVR System Evaluated in TRINITY Study - Cardiac Interventions Today
June 9, 2025—Jenscare Scientific Co., Ltd. recently announced that 30-day follow-up results from the TRINITY trial of the company’s Lux-Valve Plus transcatheter tricuspid valve replacement (TTVR) system were presented by Professor Thomas Modine, MD, at EuroPCR 2025. According to the company, TRINITY is a global prospective, multicenter, single-arm clinical trial evaluating the safety and efficacy of Lux-Valve Plus in patients with severe tricusp…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
